nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—ABCG2—Rosuvastatin—atherosclerosis	0.172	0.344	CbGbCtD
Cladribine—ABCG2—Ezetimibe—atherosclerosis	0.172	0.344	CbGbCtD
Cladribine—ABCG2—Pravastatin—atherosclerosis	0.156	0.313	CbGbCtD
Cladribine—POLE4—liver—atherosclerosis	0.0049	0.0812	CbGeAlD
Cladribine—RRM2B—connective tissue—atherosclerosis	0.00467	0.0775	CbGeAlD
Cladribine—POLE2—liver—atherosclerosis	0.00428	0.071	CbGeAlD
Cladribine—POLE3—cardiovascular system—atherosclerosis	0.00384	0.0637	CbGeAlD
Cladribine—RRM2B—adipose tissue—atherosclerosis	0.00358	0.0594	CbGeAlD
Cladribine—POLE3—adipose tissue—atherosclerosis	0.00339	0.0562	CbGeAlD
Cladribine—SLC28A3—adipose tissue—atherosclerosis	0.00317	0.0526	CbGeAlD
Cladribine—POLE3—Lovastatin—Simvastatin—atherosclerosis	0.00279	0.185	CbGdCrCtD
Cladribine—POLE3—Lovastatin—Pravastatin—atherosclerosis	0.00279	0.185	CbGdCrCtD
Cladribine—PNP—liver—atherosclerosis	0.00271	0.0449	CbGeAlD
Cladribine—POLE—adipose tissue—atherosclerosis	0.00258	0.0429	CbGeAlD
Cladribine—RRM2B—liver—atherosclerosis	0.00251	0.0417	CbGeAlD
Cladribine—RRM2—cardiovascular system—atherosclerosis	0.00241	0.04	CbGeAlD
Cladribine—POLE3—liver—atherosclerosis	0.00238	0.0394	CbGeAlD
Cladribine—POLE3—Simvastatin—Pravastatin—atherosclerosis	0.00229	0.152	CbGdCrCtD
Cladribine—POLE3—Simvastatin—Lovastatin—atherosclerosis	0.00229	0.152	CbGdCrCtD
Cladribine—POLA1—adipose tissue—atherosclerosis	0.00223	0.0369	CbGeAlD
Cladribine—RRM2—adipose tissue—atherosclerosis	0.00213	0.0353	CbGeAlD
Cladribine—RRM1—cardiovascular system—atherosclerosis	0.00201	0.0333	CbGeAlD
Cladribine—POLE—liver—atherosclerosis	0.00181	0.0301	CbGeAlD
Cladribine—RRM1—adipose tissue—atherosclerosis	0.00177	0.0293	CbGeAlD
Cladribine—POLA1—liver—atherosclerosis	0.00156	0.0259	CbGeAlD
Cladribine—RRM2—liver—atherosclerosis	0.00149	0.0248	CbGeAlD
Cladribine—DCK—adipose tissue—atherosclerosis	0.00137	0.0228	CbGeAlD
Cladribine—RRM1—liver—atherosclerosis	0.00124	0.0206	CbGeAlD
Cladribine—SLC22A1—adipose tissue—atherosclerosis	0.00117	0.0194	CbGeAlD
Cladribine—Flatulence—Rosuvastatin—atherosclerosis	0.00114	0.00371	CcSEcCtD
Cladribine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.0011	0.0036	CcSEcCtD
Cladribine—Pharyngitis—Ezetimibe—atherosclerosis	0.00109	0.00357	CcSEcCtD
Cladribine—Oedema peripheral—Ezetimibe—atherosclerosis	0.00109	0.00354	CcSEcCtD
Cladribine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00108	0.00353	CcSEcCtD
Cladribine—Erythema multiforme—Lovastatin—atherosclerosis	0.00106	0.00346	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00105	0.00342	CcSEcCtD
Cladribine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00104	0.0034	CcSEcCtD
Cladribine—Urinary tract infection—Pravastatin—atherosclerosis	0.00103	0.00335	CcSEcCtD
Cladribine—Chills—Lovastatin—atherosclerosis	0.00101	0.00329	CcSEcCtD
Cladribine—Cough—Rosuvastatin—atherosclerosis	0.00101	0.00328	CcSEcCtD
Cladribine—Angiopathy—Ezetimibe—atherosclerosis	0.001	0.00326	CcSEcCtD
Cladribine—Immune system disorder—Ezetimibe—atherosclerosis	0.000996	0.00325	CcSEcCtD
Cladribine—Erythema multiforme—Simvastatin—atherosclerosis	0.000994	0.00324	CcSEcCtD
Cladribine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000993	0.00324	CcSEcCtD
Cladribine—Alopecia—Lovastatin—atherosclerosis	0.000993	0.00324	CcSEcCtD
Cladribine—Arthralgia—Rosuvastatin—atherosclerosis	0.000983	0.0032	CcSEcCtD
Cladribine—Myalgia—Rosuvastatin—atherosclerosis	0.000983	0.0032	CcSEcCtD
Cladribine—Alopecia—Ezetimibe—atherosclerosis	0.000974	0.00318	CcSEcCtD
Cladribine—Haemoglobin—Niacin—atherosclerosis	0.00097	0.00316	CcSEcCtD
Cladribine—Mental disorder—Ezetimibe—atherosclerosis	0.000966	0.00315	CcSEcCtD
Cladribine—Haemorrhage—Niacin—atherosclerosis	0.000965	0.00315	CcSEcCtD
Cladribine—Flatulence—Lovastatin—atherosclerosis	0.000964	0.00314	CcSEcCtD
Cladribine—DCK—liver—atherosclerosis	0.000963	0.016	CbGeAlD
Cladribine—Malnutrition—Ezetimibe—atherosclerosis	0.000959	0.00313	CcSEcCtD
Cladribine—Erythema—Ezetimibe—atherosclerosis	0.000959	0.00313	CcSEcCtD
Cladribine—Oedema peripheral—Niacin—atherosclerosis	0.000951	0.0031	CcSEcCtD
Cladribine—Confusional state—Rosuvastatin—atherosclerosis	0.00095	0.0031	CcSEcCtD
Cladribine—Back pain—Lovastatin—atherosclerosis	0.000946	0.00308	CcSEcCtD
Cladribine—Flatulence—Ezetimibe—atherosclerosis	0.000945	0.00308	CcSEcCtD
Cladribine—Pharyngitis—Pravastatin—atherosclerosis	0.000943	0.00307	CcSEcCtD
Cladribine—Chills—Simvastatin—atherosclerosis	0.000943	0.00307	CcSEcCtD
Cladribine—Infection—Rosuvastatin—atherosclerosis	0.000936	0.00305	CcSEcCtD
Cladribine—Alopecia—Simvastatin—atherosclerosis	0.000929	0.00303	CcSEcCtD
Cladribine—Back pain—Ezetimibe—atherosclerosis	0.000928	0.00303	CcSEcCtD
Cladribine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000924	0.00301	CcSEcCtD
Cladribine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000922	0.00301	CcSEcCtD
Cladribine—Mental disorder—Simvastatin—atherosclerosis	0.000921	0.003	CcSEcCtD
Cladribine—Erythema—Simvastatin—atherosclerosis	0.000915	0.00298	CcSEcCtD
Cladribine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000908	0.00296	CcSEcCtD
Cladribine—Eye disorder—Niacin—atherosclerosis	0.000902	0.00294	CcSEcCtD
Cladribine—Flatulence—Simvastatin—atherosclerosis	0.000902	0.00294	CcSEcCtD
Cladribine—Erythema multiforme—Pravastatin—atherosclerosis	0.000898	0.00293	CcSEcCtD
Cladribine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00089	0.0029	CcSEcCtD
Cladribine—Anaemia—Ezetimibe—atherosclerosis	0.000887	0.00289	CcSEcCtD
Cladribine—Malaise—Lovastatin—atherosclerosis	0.000882	0.00288	CcSEcCtD
Cladribine—Cardiac disorder—Pravastatin—atherosclerosis	0.000882	0.00288	CcSEcCtD
Cladribine—Angiopathy—Niacin—atherosclerosis	0.000876	0.00285	CcSEcCtD
Cladribine—Chills—Niacin—atherosclerosis	0.000866	0.00282	CcSEcCtD
Cladribine—Malaise—Ezetimibe—atherosclerosis	0.000865	0.00282	CcSEcCtD
Cladribine—Arrhythmia—Niacin—atherosclerosis	0.000862	0.00281	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000858	0.0028	CcSEcCtD
Cladribine—Alopecia—Niacin—atherosclerosis	0.000853	0.00278	CcSEcCtD
Cladribine—Chills—Pravastatin—atherosclerosis	0.000853	0.00278	CcSEcCtD
Cladribine—Insomnia—Rosuvastatin—atherosclerosis	0.000852	0.00278	CcSEcCtD
Cladribine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000849	0.00277	CcSEcCtD
Cladribine—Arrhythmia—Pravastatin—atherosclerosis	0.000849	0.00277	CcSEcCtD
Cladribine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000846	0.00276	CcSEcCtD
Cladribine—Anaemia—Simvastatin—atherosclerosis	0.000846	0.00276	CcSEcCtD
Cladribine—Erythema—Niacin—atherosclerosis	0.00084	0.00274	CcSEcCtD
Cladribine—Malnutrition—Niacin—atherosclerosis	0.00084	0.00274	CcSEcCtD
Cladribine—Alopecia—Pravastatin—atherosclerosis	0.00084	0.00274	CcSEcCtD
Cladribine—Cough—Ezetimibe—atherosclerosis	0.000837	0.00273	CcSEcCtD
Cladribine—Myalgia—Lovastatin—atherosclerosis	0.000833	0.00271	CcSEcCtD
Cladribine—Chest pain—Lovastatin—atherosclerosis	0.000833	0.00271	CcSEcCtD
Cladribine—Arthralgia—Lovastatin—atherosclerosis	0.000833	0.00271	CcSEcCtD
Cladribine—Anxiety—Lovastatin—atherosclerosis	0.00083	0.00271	CcSEcCtD
Cladribine—Flatulence—Niacin—atherosclerosis	0.000828	0.0027	CcSEcCtD
Cladribine—Malaise—Simvastatin—atherosclerosis	0.000825	0.00269	CcSEcCtD
Cladribine—Discomfort—Lovastatin—atherosclerosis	0.000823	0.00268	CcSEcCtD
Cladribine—SLC22A1—liver—atherosclerosis	0.000822	0.0136	CbGeAlD
Cladribine—Myalgia—Ezetimibe—atherosclerosis	0.000817	0.00266	CcSEcCtD
Cladribine—Arthralgia—Ezetimibe—atherosclerosis	0.000817	0.00266	CcSEcCtD
Cladribine—Chest pain—Ezetimibe—atherosclerosis	0.000817	0.00266	CcSEcCtD
Cladribine—Flatulence—Pravastatin—atherosclerosis	0.000815	0.00266	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000811	0.00264	CcSEcCtD
Cladribine—POLE2—Fluvastatin—Rosuvastatin—atherosclerosis	0.00081	0.0537	CbGdCrCtD
Cladribine—Discomfort—Ezetimibe—atherosclerosis	0.000807	0.00263	CcSEcCtD
Cladribine—Constipation—Rosuvastatin—atherosclerosis	0.000806	0.00263	CcSEcCtD
Cladribine—Pain—Rosuvastatin—atherosclerosis	0.000806	0.00263	CcSEcCtD
Cladribine—Confusional state—Lovastatin—atherosclerosis	0.000805	0.00262	CcSEcCtD
Cladribine—Infection—Lovastatin—atherosclerosis	0.000793	0.00259	CcSEcCtD
Cladribine—Confusional state—Ezetimibe—atherosclerosis	0.00079	0.00257	CcSEcCtD
Cladribine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000782	0.00255	CcSEcCtD
Cladribine—Arthralgia—Simvastatin—atherosclerosis	0.000779	0.00254	CcSEcCtD
Cladribine—Chest pain—Simvastatin—atherosclerosis	0.000779	0.00254	CcSEcCtD
Cladribine—Myalgia—Simvastatin—atherosclerosis	0.000779	0.00254	CcSEcCtD
Cladribine—Infection—Ezetimibe—atherosclerosis	0.000778	0.00254	CcSEcCtD
Cladribine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000776	0.00253	CcSEcCtD
Cladribine—Anxiety—Simvastatin—atherosclerosis	0.000776	0.00253	CcSEcCtD
Cladribine—POLE2—Simvastatin—Lovastatin—atherosclerosis	0.000775	0.0514	CbGdCrCtD
Cladribine—POLE2—Simvastatin—Pravastatin—atherosclerosis	0.000775	0.0514	CbGdCrCtD
Cladribine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00077	0.00251	CcSEcCtD
Cladribine—Discomfort—Simvastatin—atherosclerosis	0.00077	0.00251	CcSEcCtD
Cladribine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000768	0.0025	CcSEcCtD
Cladribine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000768	0.0025	CcSEcCtD
Cladribine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000767	0.0025	CcSEcCtD
Cladribine—ABCG2—adipose tissue—atherosclerosis	0.000766	0.0127	CbGeAlD
Cladribine—Anaemia—Pravastatin—atherosclerosis	0.000765	0.00249	CcSEcCtD
Cladribine—Anorexia—Lovastatin—atherosclerosis	0.000761	0.00248	CcSEcCtD
Cladribine—Skin disorder—Ezetimibe—atherosclerosis	0.000761	0.00248	CcSEcCtD
Cladribine—Confusional state—Simvastatin—atherosclerosis	0.000753	0.00245	CcSEcCtD
Cladribine—Urticaria—Rosuvastatin—atherosclerosis	0.000748	0.00244	CcSEcCtD
Cladribine—Oedema—Simvastatin—atherosclerosis	0.000747	0.00243	CcSEcCtD
Cladribine—Malaise—Pravastatin—atherosclerosis	0.000746	0.00243	CcSEcCtD
Cladribine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000745	0.00243	CcSEcCtD
Cladribine—Infection—Simvastatin—atherosclerosis	0.000742	0.00242	CcSEcCtD
Cladribine—Cough—Niacin—atherosclerosis	0.000733	0.00239	CcSEcCtD
Cladribine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000731	0.00238	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000727	0.00237	CcSEcCtD
Cladribine—Insomnia—Lovastatin—atherosclerosis	0.000722	0.00235	CcSEcCtD
Cladribine—Cough—Pravastatin—atherosclerosis	0.000722	0.00235	CcSEcCtD
Cladribine—Paraesthesia—Lovastatin—atherosclerosis	0.000717	0.00234	CcSEcCtD
Cladribine—Arthralgia—Niacin—atherosclerosis	0.000715	0.00233	CcSEcCtD
Cladribine—Myalgia—Niacin—atherosclerosis	0.000715	0.00233	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000713	0.00233	CcSEcCtD
Cladribine—Anorexia—Simvastatin—atherosclerosis	0.000712	0.00232	CcSEcCtD
Cladribine—Dyspnoea—Lovastatin—atherosclerosis	0.000712	0.00232	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00071	0.00232	CcSEcCtD
Cladribine—Insomnia—Ezetimibe—atherosclerosis	0.000708	0.00231	CcSEcCtD
Cladribine—Myalgia—Pravastatin—atherosclerosis	0.000704	0.0023	CcSEcCtD
Cladribine—Arthralgia—Pravastatin—atherosclerosis	0.000704	0.0023	CcSEcCtD
Cladribine—Chest pain—Pravastatin—atherosclerosis	0.000704	0.0023	CcSEcCtD
Cladribine—Paraesthesia—Ezetimibe—atherosclerosis	0.000703	0.00229	CcSEcCtD
Cladribine—Anxiety—Pravastatin—atherosclerosis	0.000702	0.00229	CcSEcCtD
Cladribine—Dyspnoea—Ezetimibe—atherosclerosis	0.000698	0.00228	CcSEcCtD
Cladribine—Discomfort—Pravastatin—atherosclerosis	0.000696	0.00227	CcSEcCtD
Cladribine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000694	0.00226	CcSEcCtD
Cladribine—Decreased appetite—Lovastatin—atherosclerosis	0.000694	0.00226	CcSEcCtD
Cladribine—Fatigue—Lovastatin—atherosclerosis	0.000688	0.00224	CcSEcCtD
Cladribine—Oedema—Niacin—atherosclerosis	0.000686	0.00224	CcSEcCtD
Cladribine—Pain—Lovastatin—atherosclerosis	0.000683	0.00223	CcSEcCtD
Cladribine—Constipation—Lovastatin—atherosclerosis	0.000683	0.00223	CcSEcCtD
Cladribine—Confusional state—Pravastatin—atherosclerosis	0.000681	0.00222	CcSEcCtD
Cladribine—Decreased appetite—Ezetimibe—atherosclerosis	0.000681	0.00222	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00068	0.00222	CcSEcCtD
Cladribine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000676	0.0022	CcSEcCtD
Cladribine—Asthenia—Rosuvastatin—atherosclerosis	0.000676	0.0022	CcSEcCtD
Cladribine—Insomnia—Simvastatin—atherosclerosis	0.000675	0.0022	CcSEcCtD
Cladribine—Oedema—Pravastatin—atherosclerosis	0.000675	0.0022	CcSEcCtD
Cladribine—Fatigue—Ezetimibe—atherosclerosis	0.000675	0.0022	CcSEcCtD
Cladribine—Infection—Pravastatin—atherosclerosis	0.000671	0.00219	CcSEcCtD
Cladribine—Paraesthesia—Simvastatin—atherosclerosis	0.000671	0.00219	CcSEcCtD
Cladribine—Pain—Ezetimibe—atherosclerosis	0.00067	0.00218	CcSEcCtD
Cladribine—Constipation—Ezetimibe—atherosclerosis	0.00067	0.00218	CcSEcCtD
Cladribine—Tachycardia—Niacin—atherosclerosis	0.000669	0.00218	CcSEcCtD
Cladribine—Pruritus—Rosuvastatin—atherosclerosis	0.000666	0.00217	CcSEcCtD
Cladribine—Skin disorder—Niacin—atherosclerosis	0.000666	0.00217	CcSEcCtD
Cladribine—Dyspnoea—Simvastatin—atherosclerosis	0.000666	0.00217	CcSEcCtD
Cladribine—Hyperhidrosis—Niacin—atherosclerosis	0.000663	0.00216	CcSEcCtD
Cladribine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000661	0.00215	CcSEcCtD
Cladribine—POLE2—Pitavastatin—Rosuvastatin—atherosclerosis	0.000661	0.0438	CbGdCrCtD
Cladribine—Feeling abnormal—Lovastatin—atherosclerosis	0.000658	0.00214	CcSEcCtD
Cladribine—Anorexia—Niacin—atherosclerosis	0.000654	0.00213	CcSEcCtD
Cladribine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000653	0.00213	CcSEcCtD
Cladribine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000653	0.00213	CcSEcCtD
Cladribine—Decreased appetite—Simvastatin—atherosclerosis	0.000649	0.00212	CcSEcCtD
Cladribine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000645	0.0021	CcSEcCtD
Cladribine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000645	0.0021	CcSEcCtD
Cladribine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000645	0.0021	CcSEcCtD
Cladribine—Fatigue—Simvastatin—atherosclerosis	0.000644	0.0021	CcSEcCtD
Cladribine—Anorexia—Pravastatin—atherosclerosis	0.000644	0.0021	CcSEcCtD
Cladribine—Hypotension—Niacin—atherosclerosis	0.000641	0.00209	CcSEcCtD
Cladribine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00064	0.00209	CcSEcCtD
Cladribine—Constipation—Simvastatin—atherosclerosis	0.000639	0.00208	CcSEcCtD
Cladribine—Pain—Simvastatin—atherosclerosis	0.000639	0.00208	CcSEcCtD
Cladribine—Urticaria—Lovastatin—atherosclerosis	0.000634	0.00207	CcSEcCtD
Cladribine—Abdominal pain—Lovastatin—atherosclerosis	0.000631	0.00206	CcSEcCtD
Cladribine—Body temperature increased—Lovastatin—atherosclerosis	0.000631	0.00206	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000625	0.00204	CcSEcCtD
Cladribine—Dizziness—Rosuvastatin—atherosclerosis	0.000623	0.00203	CcSEcCtD
Cladribine—Urticaria—Ezetimibe—atherosclerosis	0.000622	0.00203	CcSEcCtD
Cladribine—Insomnia—Niacin—atherosclerosis	0.00062	0.00202	CcSEcCtD
Cladribine—Body temperature increased—Ezetimibe—atherosclerosis	0.000619	0.00202	CcSEcCtD
Cladribine—Abdominal pain—Ezetimibe—atherosclerosis	0.000619	0.00202	CcSEcCtD
Cladribine—Paraesthesia—Niacin—atherosclerosis	0.000616	0.00201	CcSEcCtD
Cladribine—Feeling abnormal—Simvastatin—atherosclerosis	0.000615	0.00201	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000615	0.00201	CcSEcCtD
Cladribine—Dyspnoea—Niacin—atherosclerosis	0.000611	0.00199	CcSEcCtD
Cladribine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000611	0.00199	CcSEcCtD
Cladribine—Insomnia—Pravastatin—atherosclerosis	0.000611	0.00199	CcSEcCtD
Cladribine—Somnolence—Niacin—atherosclerosis	0.00061	0.00199	CcSEcCtD
Cladribine—Paraesthesia—Pravastatin—atherosclerosis	0.000606	0.00198	CcSEcCtD
Cladribine—Dyspnoea—Pravastatin—atherosclerosis	0.000602	0.00196	CcSEcCtD
Cladribine—PNP—Simvastatin—Lovastatin—atherosclerosis	0.000598	0.0397	CbGdCrCtD
Cladribine—PNP—Simvastatin—Pravastatin—atherosclerosis	0.000598	0.0397	CbGdCrCtD
Cladribine—Decreased appetite—Niacin—atherosclerosis	0.000596	0.00194	CcSEcCtD
Cladribine—Rash—Rosuvastatin—atherosclerosis	0.000594	0.00194	CcSEcCtD
Cladribine—Dermatitis—Rosuvastatin—atherosclerosis	0.000593	0.00193	CcSEcCtD
Cladribine—Urticaria—Simvastatin—atherosclerosis	0.000593	0.00193	CcSEcCtD
Cladribine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000592	0.00193	CcSEcCtD
Cladribine—Body temperature increased—Simvastatin—atherosclerosis	0.00059	0.00192	CcSEcCtD
Cladribine—Abdominal pain—Simvastatin—atherosclerosis	0.00059	0.00192	CcSEcCtD
Cladribine—Headache—Rosuvastatin—atherosclerosis	0.00059	0.00192	CcSEcCtD
Cladribine—Hypersensitivity—Lovastatin—atherosclerosis	0.000588	0.00192	CcSEcCtD
Cladribine—Decreased appetite—Pravastatin—atherosclerosis	0.000587	0.00191	CcSEcCtD
Cladribine—Pain—Niacin—atherosclerosis	0.000586	0.00191	CcSEcCtD
Cladribine—Fatigue—Pravastatin—atherosclerosis	0.000582	0.0019	CcSEcCtD
Cladribine—Pain—Pravastatin—atherosclerosis	0.000577	0.00188	CcSEcCtD
Cladribine—Constipation—Pravastatin—atherosclerosis	0.000577	0.00188	CcSEcCtD
Cladribine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000577	0.00188	CcSEcCtD
Cladribine—Asthenia—Lovastatin—atherosclerosis	0.000573	0.00187	CcSEcCtD
Cladribine—Pruritus—Lovastatin—atherosclerosis	0.000565	0.00184	CcSEcCtD
Cladribine—Asthenia—Ezetimibe—atherosclerosis	0.000562	0.00183	CcSEcCtD
Cladribine—Gastrointestinal pain—Niacin—atherosclerosis	0.000561	0.00183	CcSEcCtD
Cladribine—Nausea—Rosuvastatin—atherosclerosis	0.00056	0.00182	CcSEcCtD
Cladribine—Feeling abnormal—Pravastatin—atherosclerosis	0.000556	0.00181	CcSEcCtD
Cladribine—Pruritus—Ezetimibe—atherosclerosis	0.000554	0.00181	CcSEcCtD
Cladribine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000552	0.0018	CcSEcCtD
Cladribine—Hypersensitivity—Simvastatin—atherosclerosis	0.00055	0.00179	CcSEcCtD
Cladribine—Diarrhoea—Lovastatin—atherosclerosis	0.000546	0.00178	CcSEcCtD
Cladribine—Urticaria—Niacin—atherosclerosis	0.000545	0.00178	CcSEcCtD
Cladribine—Abdominal pain—Niacin—atherosclerosis	0.000542	0.00177	CcSEcCtD
Cladribine—Body temperature increased—Niacin—atherosclerosis	0.000542	0.00177	CcSEcCtD
Cladribine—ABCG2—liver—atherosclerosis	0.000537	0.00891	CbGeAlD
Cladribine—Urticaria—Pravastatin—atherosclerosis	0.000536	0.00175	CcSEcCtD
Cladribine—Asthenia—Simvastatin—atherosclerosis	0.000536	0.00175	CcSEcCtD
Cladribine—Diarrhoea—Ezetimibe—atherosclerosis	0.000536	0.00175	CcSEcCtD
Cladribine—Abdominal pain—Pravastatin—atherosclerosis	0.000534	0.00174	CcSEcCtD
Cladribine—Body temperature increased—Pravastatin—atherosclerosis	0.000534	0.00174	CcSEcCtD
Cladribine—Pruritus—Simvastatin—atherosclerosis	0.000528	0.00172	CcSEcCtD
Cladribine—Dizziness—Lovastatin—atherosclerosis	0.000528	0.00172	CcSEcCtD
Cladribine—Dizziness—Ezetimibe—atherosclerosis	0.000518	0.00169	CcSEcCtD
Cladribine—Diarrhoea—Simvastatin—atherosclerosis	0.000511	0.00167	CcSEcCtD
Cladribine—Vomiting—Lovastatin—atherosclerosis	0.000508	0.00165	CcSEcCtD
Cladribine—Hypersensitivity—Niacin—atherosclerosis	0.000505	0.00165	CcSEcCtD
Cladribine—Rash—Lovastatin—atherosclerosis	0.000503	0.00164	CcSEcCtD
Cladribine—Dermatitis—Lovastatin—atherosclerosis	0.000503	0.00164	CcSEcCtD
Cladribine—Headache—Lovastatin—atherosclerosis	0.0005	0.00163	CcSEcCtD
Cladribine—Vomiting—Ezetimibe—atherosclerosis	0.000498	0.00162	CcSEcCtD
Cladribine—Hypersensitivity—Pravastatin—atherosclerosis	0.000497	0.00162	CcSEcCtD
Cladribine—Dizziness—Simvastatin—atherosclerosis	0.000494	0.00161	CcSEcCtD
Cladribine—Rash—Ezetimibe—atherosclerosis	0.000494	0.00161	CcSEcCtD
Cladribine—Dermatitis—Ezetimibe—atherosclerosis	0.000493	0.00161	CcSEcCtD
Cladribine—Asthenia—Niacin—atherosclerosis	0.000492	0.0016	CcSEcCtD
Cladribine—Headache—Ezetimibe—atherosclerosis	0.000491	0.0016	CcSEcCtD
Cladribine—Pruritus—Niacin—atherosclerosis	0.000485	0.00158	CcSEcCtD
Cladribine—Asthenia—Pravastatin—atherosclerosis	0.000484	0.00158	CcSEcCtD
Cladribine—Pruritus—Pravastatin—atherosclerosis	0.000478	0.00156	CcSEcCtD
Cladribine—Vomiting—Simvastatin—atherosclerosis	0.000475	0.00155	CcSEcCtD
Cladribine—Nausea—Lovastatin—atherosclerosis	0.000474	0.00155	CcSEcCtD
Cladribine—Rash—Simvastatin—atherosclerosis	0.000471	0.00153	CcSEcCtD
Cladribine—Dermatitis—Simvastatin—atherosclerosis	0.00047	0.00153	CcSEcCtD
Cladribine—Diarrhoea—Niacin—atherosclerosis	0.000469	0.00153	CcSEcCtD
Cladribine—Headache—Simvastatin—atherosclerosis	0.000468	0.00153	CcSEcCtD
Cladribine—Nausea—Ezetimibe—atherosclerosis	0.000465	0.00152	CcSEcCtD
Cladribine—Diarrhoea—Pravastatin—atherosclerosis	0.000462	0.00151	CcSEcCtD
Cladribine—Dizziness—Niacin—atherosclerosis	0.000453	0.00148	CcSEcCtD
Cladribine—Dizziness—Pravastatin—atherosclerosis	0.000446	0.00146	CcSEcCtD
Cladribine—Nausea—Simvastatin—atherosclerosis	0.000444	0.00145	CcSEcCtD
Cladribine—Vomiting—Niacin—atherosclerosis	0.000436	0.00142	CcSEcCtD
Cladribine—Rash—Niacin—atherosclerosis	0.000432	0.00141	CcSEcCtD
Cladribine—Dermatitis—Niacin—atherosclerosis	0.000432	0.00141	CcSEcCtD
Cladribine—Headache—Niacin—atherosclerosis	0.00043	0.0014	CcSEcCtD
Cladribine—Vomiting—Pravastatin—atherosclerosis	0.000429	0.0014	CcSEcCtD
Cladribine—Rash—Pravastatin—atherosclerosis	0.000426	0.00139	CcSEcCtD
Cladribine—Dermatitis—Pravastatin—atherosclerosis	0.000425	0.00139	CcSEcCtD
Cladribine—Headache—Pravastatin—atherosclerosis	0.000423	0.00138	CcSEcCtD
Cladribine—Nausea—Niacin—atherosclerosis	0.000407	0.00133	CcSEcCtD
Cladribine—Nausea—Pravastatin—atherosclerosis	0.000401	0.00131	CcSEcCtD
Cladribine—DCK—Simvastatin—Pravastatin—atherosclerosis	0.000349	0.0232	CbGdCrCtD
Cladribine—DCK—Simvastatin—Lovastatin—atherosclerosis	0.000349	0.0232	CbGdCrCtD
Cladribine—SLC22A2—Metabolism—PLTP—atherosclerosis	8.24e-05	0.000695	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LDLRAP1—atherosclerosis	8.16e-05	0.000689	CbGpPWpGaD
Cladribine—POLE—Mitotic M-M/G1 phases—MAPK3—atherosclerosis	8.01e-05	0.000676	CbGpPWpGaD
Cladribine—RRM2—Metabolism—HMGCR—atherosclerosis	8.01e-05	0.000676	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—PRKCG—atherosclerosis	8.01e-05	0.000675	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	7.99e-05	0.000674	CbGpPWpGaD
Cladribine—DCK—Metabolism—SCARB1—atherosclerosis	7.93e-05	0.000669	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTGS2—atherosclerosis	7.85e-05	0.000662	CbGpPWpGaD
Cladribine—PNP—Metabolism—ALB—atherosclerosis	7.78e-05	0.000656	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PLTP—atherosclerosis	7.68e-05	0.000647	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	7.61e-05	0.000642	CbGpPWpGaD
Cladribine—DCK—Metabolism—HMGCR—atherosclerosis	7.49e-05	0.000631	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—PRKCG—atherosclerosis	7.46e-05	0.000629	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—SERPINE1—atherosclerosis	7.45e-05	0.000628	CbGpPWpGaD
Cladribine—PNP—Metabolism—NOS3—atherosclerosis	7.44e-05	0.000627	CbGpPWpGaD
Cladribine—RRM1—Metabolism—HMOX1—atherosclerosis	7.44e-05	0.000627	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LTA4H—atherosclerosis	7.22e-05	0.000609	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCG8—atherosclerosis	7.22e-05	0.000609	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ABCA1—atherosclerosis	7.14e-05	0.000602	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCG8—atherosclerosis	7.14e-05	0.000602	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LTA4H—atherosclerosis	7.14e-05	0.000602	CbGpPWpGaD
Cladribine—RRM1—Metabolism—APOB—atherosclerosis	7.13e-05	0.000601	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—CETP—atherosclerosis	7.07e-05	0.000597	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—CETP—atherosclerosis	7e-05	0.00059	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GSTM1—atherosclerosis	6.93e-05	0.000585	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—IL6—atherosclerosis	6.93e-05	0.000584	CbGpPWpGaD
Cladribine—RRM1—Metabolism—LPL—atherosclerosis	6.8e-05	0.000574	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTGS2—atherosclerosis	6.8e-05	0.000574	CbGpPWpGaD
Cladribine—DCK—Metabolism—ABCA1—atherosclerosis	6.67e-05	0.000563	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LTA4H—atherosclerosis	6.66e-05	0.000561	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCG8—atherosclerosis	6.66e-05	0.000561	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GPX1—atherosclerosis	6.64e-05	0.00056	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—CETP—atherosclerosis	6.52e-05	0.00055	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CD36—atherosclerosis	6.47e-05	0.000545	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—AKT1—atherosclerosis	6.39e-05	0.000539	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MAPK3—atherosclerosis	6.24e-05	0.000526	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.23e-05	0.000526	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.17e-05	0.00052	CbGpPWpGaD
Cladribine—RRM2—Metabolism—HMOX1—atherosclerosis	6.13e-05	0.000517	CbGpPWpGaD
Cladribine—RRM1—Metabolism—MTHFR—atherosclerosis	6.13e-05	0.000517	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PPARA—atherosclerosis	6.01e-05	0.000507	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MAPK3—atherosclerosis	5.99e-05	0.000505	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	5.95e-05	0.000502	CbGpPWpGaD
Cladribine—RRM2—Metabolism—APOB—atherosclerosis	5.87e-05	0.000495	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AGT—atherosclerosis	5.82e-05	0.000491	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.75e-05	0.000485	CbGpPWpGaD
Cladribine—DCK—Metabolism—HMOX1—atherosclerosis	5.73e-05	0.000483	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	5.72e-05	0.000482	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—MAPK3—atherosclerosis	5.71e-05	0.000481	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GSTM1—atherosclerosis	5.71e-05	0.000481	CbGpPWpGaD
Cladribine—RRM1—Metabolism—APOE—atherosclerosis	5.7e-05	0.000481	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCG1—atherosclerosis	5.7e-05	0.000481	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CAV1—atherosclerosis	5.65e-05	0.000477	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCG1—atherosclerosis	5.64e-05	0.000476	CbGpPWpGaD
Cladribine—RRM1—Metabolism—APOA1—atherosclerosis	5.64e-05	0.000476	CbGpPWpGaD
Cladribine—RRM2—Metabolism—LPL—atherosclerosis	5.6e-05	0.000473	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MAPK3—atherosclerosis	5.58e-05	0.000471	CbGpPWpGaD
Cladribine—DCK—Metabolism—APOB—atherosclerosis	5.48e-05	0.000462	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GPX1—atherosclerosis	5.47e-05	0.000461	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—FABP4—atherosclerosis	5.36e-05	0.000452	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LCAT—atherosclerosis	5.36e-05	0.000452	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MAPK3—atherosclerosis	5.36e-05	0.000452	CbGpPWpGaD
Cladribine—DCK—Metabolism—GSTM1—atherosclerosis	5.33e-05	0.00045	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	5.33e-05	0.00045	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CD36—atherosclerosis	5.32e-05	0.000449	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—FABP4—atherosclerosis	5.31e-05	0.000448	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LCAT—atherosclerosis	5.31e-05	0.000448	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—PLG—atherosclerosis	5.3e-05	0.000447	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOA4—atherosclerosis	5.26e-05	0.000444	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCG1—atherosclerosis	5.26e-05	0.000444	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—PLG—atherosclerosis	5.25e-05	0.000442	CbGpPWpGaD
Cladribine—DCK—Metabolism—LPL—atherosclerosis	5.24e-05	0.000442	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOA4—atherosclerosis	5.21e-05	0.000439	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP7A1—atherosclerosis	5.17e-05	0.000436	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CG—atherosclerosis	5.15e-05	0.000434	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP7A1—atherosclerosis	5.12e-05	0.000432	CbGpPWpGaD
Cladribine—DCK—Metabolism—GPX1—atherosclerosis	5.11e-05	0.000431	CbGpPWpGaD
Cladribine—RRM2—Metabolism—MTHFR—atherosclerosis	5.05e-05	0.000425	CbGpPWpGaD
Cladribine—DCK—Metabolism—CD36—atherosclerosis	4.98e-05	0.00042	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PPARG—atherosclerosis	4.97e-05	0.000419	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARA—atherosclerosis	4.95e-05	0.000417	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—FABP4—atherosclerosis	4.95e-05	0.000417	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LCAT—atherosclerosis	4.95e-05	0.000417	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.89e-05	0.000413	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.89e-05	0.000412	CbGpPWpGaD
Cladribine—RRM1—Metabolism—INS—atherosclerosis	4.87e-05	0.000411	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOA4—atherosclerosis	4.86e-05	0.000409	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MAPK3—atherosclerosis	4.85e-05	0.000409	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.84e-05	0.000408	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AGT—atherosclerosis	4.79e-05	0.000404	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP27A1—atherosclerosis	4.78e-05	0.000403	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP7A1—atherosclerosis	4.77e-05	0.000402	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP27A1—atherosclerosis	4.73e-05	0.000399	CbGpPWpGaD
Cladribine—DCK—Metabolism—MTHFR—atherosclerosis	4.71e-05	0.000398	CbGpPWpGaD
Cladribine—RRM2—Metabolism—APOE—atherosclerosis	4.7e-05	0.000396	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—APOB—atherosclerosis	4.69e-05	0.000395	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CAV1—atherosclerosis	4.65e-05	0.000392	CbGpPWpGaD
Cladribine—RRM2—Metabolism—APOA1—atherosclerosis	4.64e-05	0.000392	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—APOB—atherosclerosis	4.64e-05	0.000391	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARA—atherosclerosis	4.63e-05	0.00039	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOA2—atherosclerosis	4.53e-05	0.000382	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALOX5AP—atherosclerosis	4.53e-05	0.000382	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALOX15—atherosclerosis	4.53e-05	0.000382	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PLA2G2A—atherosclerosis	4.53e-05	0.000382	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.51e-05	0.000381	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOA2—atherosclerosis	4.48e-05	0.000378	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PLA2G2A—atherosclerosis	4.48e-05	0.000378	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALOX5AP—atherosclerosis	4.48e-05	0.000378	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALOX15—atherosclerosis	4.48e-05	0.000378	CbGpPWpGaD
Cladribine—DCK—Metabolism—AGT—atherosclerosis	4.48e-05	0.000378	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCG5—atherosclerosis	4.48e-05	0.000377	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALB—atherosclerosis	4.47e-05	0.000377	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCG5—atherosclerosis	4.43e-05	0.000374	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP27A1—atherosclerosis	4.41e-05	0.000372	CbGpPWpGaD
Cladribine—DCK—Metabolism—APOE—atherosclerosis	4.39e-05	0.00037	CbGpPWpGaD
Cladribine—DCK—Metabolism—CAV1—atherosclerosis	4.35e-05	0.000367	CbGpPWpGaD
Cladribine—DCK—Metabolism—APOA1—atherosclerosis	4.34e-05	0.000366	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LPA—atherosclerosis	4.32e-05	0.000365	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—APOB—atherosclerosis	4.32e-05	0.000365	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LPA—atherosclerosis	4.28e-05	0.000361	CbGpPWpGaD
Cladribine—RRM1—Metabolism—NOS3—atherosclerosis	4.27e-05	0.00036	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MAPK3—atherosclerosis	4.27e-05	0.00036	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CG—atherosclerosis	4.24e-05	0.000357	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—BGN—atherosclerosis	4.19e-05	0.000353	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOA2—atherosclerosis	4.18e-05	0.000352	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PLA2G2A—atherosclerosis	4.18e-05	0.000352	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALOX15—atherosclerosis	4.18e-05	0.000352	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALOX5AP—atherosclerosis	4.18e-05	0.000352	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOA5—atherosclerosis	4.14e-05	0.000349	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—BGN—atherosclerosis	4.14e-05	0.000349	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCG5—atherosclerosis	4.13e-05	0.000348	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOA5—atherosclerosis	4.1e-05	0.000346	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARG—atherosclerosis	4.09e-05	0.000345	CbGpPWpGaD
Cladribine—RRM2—Metabolism—INS—atherosclerosis	4.01e-05	0.000338	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PLA2G1B—atherosclerosis	3.99e-05	0.000336	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LPA—atherosclerosis	3.99e-05	0.000336	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CG—atherosclerosis	3.96e-05	0.000334	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.95e-05	0.000333	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PLA2G1B—atherosclerosis	3.95e-05	0.000333	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—atherosclerosis	3.94e-05	0.000333	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.91e-05	0.00033	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS2—atherosclerosis	3.91e-05	0.00033	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—BGN—atherosclerosis	3.86e-05	0.000326	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALOX5—atherosclerosis	3.85e-05	0.000325	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARG—atherosclerosis	3.82e-05	0.000322	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOA5—atherosclerosis	3.82e-05	0.000322	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MAPK3—atherosclerosis	3.82e-05	0.000322	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALOX5—atherosclerosis	3.81e-05	0.000322	CbGpPWpGaD
Cladribine—DCK—Metabolism—INS—atherosclerosis	3.75e-05	0.000316	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.71e-05	0.000313	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PLA2G1B—atherosclerosis	3.68e-05	0.00031	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALB—atherosclerosis	3.68e-05	0.00031	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.67e-05	0.000309	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.65e-05	0.000307	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALOX5—atherosclerosis	3.55e-05	0.0003	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NOS3—atherosclerosis	3.52e-05	0.000297	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NAMPT—atherosclerosis	3.46e-05	0.000291	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALB—atherosclerosis	3.44e-05	0.00029	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LIPC—atherosclerosis	3.43e-05	0.00029	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—atherosclerosis	3.42e-05	0.000288	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NAMPT—atherosclerosis	3.42e-05	0.000288	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.42e-05	0.000288	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOC3—atherosclerosis	3.41e-05	0.000288	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LIPC—atherosclerosis	3.4e-05	0.000287	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LDLR—atherosclerosis	3.39e-05	0.000286	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOC3—atherosclerosis	3.38e-05	0.000285	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LDLR—atherosclerosis	3.36e-05	0.000283	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CETP—atherosclerosis	3.31e-05	0.000279	CbGpPWpGaD
Cladribine—DCK—Metabolism—NOS3—atherosclerosis	3.29e-05	0.000277	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CETP—atherosclerosis	3.28e-05	0.000277	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—atherosclerosis	3.27e-05	0.000276	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS2—atherosclerosis	3.22e-05	0.000271	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NAMPT—atherosclerosis	3.19e-05	0.000269	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SCARB1—atherosclerosis	3.17e-05	0.000268	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LIPC—atherosclerosis	3.17e-05	0.000267	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOC3—atherosclerosis	3.15e-05	0.000265	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SCARB1—atherosclerosis	3.14e-05	0.000265	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LDLR—atherosclerosis	3.13e-05	0.000264	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CETP—atherosclerosis	3.06e-05	0.000258	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS2—atherosclerosis	3.01e-05	0.000254	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HMGCR—atherosclerosis	3e-05	0.000253	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HMGCR—atherosclerosis	2.97e-05	0.00025	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.94e-05	0.000248	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SCARB1—atherosclerosis	2.93e-05	0.000247	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.91e-05	0.000245	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HMGCR—atherosclerosis	2.76e-05	0.000233	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.71e-05	0.000228	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCA1—atherosclerosis	2.67e-05	0.000225	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCA1—atherosclerosis	2.64e-05	0.000223	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCA1—atherosclerosis	2.46e-05	0.000208	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HMOX1—atherosclerosis	2.29e-05	0.000193	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HMOX1—atherosclerosis	2.27e-05	0.000191	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOB—atherosclerosis	2.19e-05	0.000185	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOB—atherosclerosis	2.17e-05	0.000183	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTM1—atherosclerosis	2.13e-05	0.00018	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HMOX1—atherosclerosis	2.11e-05	0.000178	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTM1—atherosclerosis	2.11e-05	0.000178	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LPL—atherosclerosis	2.1e-05	0.000177	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LPL—atherosclerosis	2.07e-05	0.000175	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GPX1—atherosclerosis	2.04e-05	0.000172	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOB—atherosclerosis	2.02e-05	0.000171	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GPX1—atherosclerosis	2.02e-05	0.000171	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CD36—atherosclerosis	1.99e-05	0.000168	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CD36—atherosclerosis	1.97e-05	0.000166	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTM1—atherosclerosis	1.97e-05	0.000166	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—atherosclerosis	1.96e-05	0.000166	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LPL—atherosclerosis	1.93e-05	0.000163	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTHFR—atherosclerosis	1.89e-05	0.000159	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GPX1—atherosclerosis	1.89e-05	0.000159	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTHFR—atherosclerosis	1.87e-05	0.000157	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARA—atherosclerosis	1.85e-05	0.000156	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CD36—atherosclerosis	1.84e-05	0.000155	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARA—atherosclerosis	1.83e-05	0.000154	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AGT—atherosclerosis	1.79e-05	0.000151	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AGT—atherosclerosis	1.77e-05	0.00015	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOE—atherosclerosis	1.76e-05	0.000148	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTHFR—atherosclerosis	1.74e-05	0.000147	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CAV1—atherosclerosis	1.74e-05	0.000147	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOE—atherosclerosis	1.74e-05	0.000147	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOA1—atherosclerosis	1.74e-05	0.000146	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CAV1—atherosclerosis	1.72e-05	0.000145	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOA1—atherosclerosis	1.72e-05	0.000145	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARA—atherosclerosis	1.71e-05	0.000144	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AGT—atherosclerosis	1.65e-05	0.000139	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOE—atherosclerosis	1.62e-05	0.000137	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—atherosclerosis	1.62e-05	0.000136	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CAV1—atherosclerosis	1.61e-05	0.000135	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOA1—atherosclerosis	1.6e-05	0.000135	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CG—atherosclerosis	1.59e-05	0.000134	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CG—atherosclerosis	1.57e-05	0.000132	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARG—atherosclerosis	1.53e-05	0.000129	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARG—atherosclerosis	1.51e-05	0.000128	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—atherosclerosis	1.51e-05	0.000127	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—INS—atherosclerosis	1.5e-05	0.000127	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—INS—atherosclerosis	1.49e-05	0.000125	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CG—atherosclerosis	1.46e-05	0.000123	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARG—atherosclerosis	1.41e-05	0.000119	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—INS—atherosclerosis	1.38e-05	0.000117	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALB—atherosclerosis	1.38e-05	0.000116	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALB—atherosclerosis	1.36e-05	0.000115	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NOS3—atherosclerosis	1.32e-05	0.000111	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NOS3—atherosclerosis	1.3e-05	0.00011	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALB—atherosclerosis	1.27e-05	0.000107	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NOS3—atherosclerosis	1.21e-05	0.000102	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS2—atherosclerosis	1.2e-05	0.000102	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.19e-05	0.0001	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS2—atherosclerosis	1.11e-05	9.36e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—atherosclerosis	6.05e-06	5.1e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—atherosclerosis	5.99e-06	5.05e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—atherosclerosis	5.58e-06	4.71e-05	CbGpPWpGaD
